Envoy Medical, Inc.
COCH
$1.48
$0.021.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -28.80% | 15.35% | 38.53% | 38.79% | 33.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.80% | 15.35% | 38.53% | 38.79% | 33.33% |
| Cost of Revenue | -2.37% | 20.97% | 38.22% | 13.54% | 10.47% |
| Gross Profit | -16.44% | -24.08% | -38.03% | -1.15% | 1.55% |
| SG&A Expenses | -4.14% | 50.76% | 55.11% | 110.89% | 157.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.32% | 47.01% | 53.12% | 81.81% | 108.82% |
| Operating Income | -4.89% | -47.54% | -53.37% | -82.68% | -110.88% |
| Income Before Tax | 30.29% | 42.13% | 65.54% | 16.32% | -87.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.29% | 42.13% | 65.54% | 16.32% | -87.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.29% | 42.13% | 65.54% | 16.32% | -87.35% |
| EBIT | -4.89% | -47.54% | -53.37% | -82.68% | -110.88% |
| EBITDA | -4.70% | -47.47% | -53.42% | -82.89% | -111.17% |
| EPS Basic | 46.60% | 62.19% | 77.83% | 26.64% | -117.55% |
| Normalized Basic EPS | 51.41% | 55.68% | 50.84% | -131.48% | -287.60% |
| EPS Diluted | 46.61% | 62.20% | 77.57% | 26.25% | -118.42% |
| Normalized Diluted EPS | 50.78% | 55.15% | 52.13% | -128.44% | -282.64% |
| Average Basic Shares Outstanding | 52.83% | 91.06% | 68.27% | -65.40% | -83.53% |
| Average Diluted Shares Outstanding | 49.78% | 86.46% | 70.74% | -64.81% | -83.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |